Prolactin does not enhance glucose-stimulated insulin release in red deer stags.
Red deer stags have a seasonal pattern of insulin secretion that is characterized by both elevated basal and glucose-stimulated insulin release in summer compared with winter. Since the seasonal timing of this pattern is similar to that of prolactin and growth rate, the objectives of this study were: first, to determine whether prolactin is associated with the enhanced secretion of insulin during the summer growth period, and second, to determine whether a chronic reduction in plasma prolactin levels would alter body composition. Prolactin was suppressed in plasma using a long-acting form of the dopamine agonist bromocriptine (parlodel LA), which was administered at one of four doses (0-0.3 mg/kg) to each of four groups of castrate stags. Bromocriptine was administered during two 6-wk periods; the first in winter and the second in summer. During the sixth wk of each period, each animal was given three IVGTT at the following glucose doses (10 mg/kg, 70 mg/kg, and 200 mg/kg). Two d later, ovine prolactin was administered to each animal (0.08 mg/kg) and a single IVGTT (70 mg/kg) was given 2 hr later. Body composition was determined by the tritriated water dilution method at the beginning and end of each 6-wk treatment. Chronic suppression of prolactin during winter or summer did not significantly alter the amount of insulin released after each IVGTT, nor did it significantly alter body composition. Furthermore, acute administration of prolactin did not significantly enhance the release of insulin following an IVGTT, during winter or summer treatment periods. It is concluded that elevated levels of prolactin in summer do not enhance the release of insulin to glucose in red deer. Furthermore, a reduction in growth rate following a reduction in plasma prolactin is not associated with a change in body composition.
McMahon
C D
CD
AgResearch, Invermay Agricultural Centre, Mosgiel, New Zealand.
Corson
I D
ID
Littlejohn
R P
RP
Stuart
S K
SK
Veenvliet
B A
BA
Webster
J R
JR
Suttie
J M
JM
D000818:Animals; D019540:Area Under Curve; D001823:Body Composition / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D001971:Bromocriptine / Q000494:pharmacology; D003670:Deer / Q000254:growth & development / Q000378:metabolism* / Q000502:physiology; D018491:Dopamine Agonists / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005947:Glucose / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D005951:Glucose Tolerance Test / Q000662:veterinary; D007328:Insulin / Q000378:metabolism* / Q000493:pharmacokinetics; D008297:Male; D011388:Prolactin / Q000097:blood / Q000494:pharmacology*; D012621:Seasons; D012756:Sheep; D013997:Time Factors
D018491:Dopamine Agonists; D007328:Insulin; D001971:Bromocriptine; D011388:Prolactin; D005947:Glucose